Combination drug for parenteral administration containing methylethyl pyridinol hydrochloride or succinate and riboflavin
RU2550820C1
Copolymers of 4-vinylpyridine or 2-methyl-5-vinylpyridine and n-vinylpyrrolidone with terminal cyanovaleric acid residue and use thereof to treat pneumoconiosis
RU2528912C1
Eye drops based on pharmaceutically tolerable additive salts of acid and methyl ethyl encephabol containing composition of vitamins b
RU2533276C1
Eye drops based on composition of pharmaceutically acceptable additive acid salts and methylethyl pyridonol and taurine containing composition of group b vitamins
RU2533113C1
N-vinylpyrrolidone-based copolymers in form of pharmaceutically acceptable salts of acids
RU2524649C1
Method for producing microspheres for preparing injectable dosage form of diclofenac, composition and dosage form
RU2510264C1
Ophthalmic preparation presented in form of eye drops and containing branched polyhexamethylene guanidines
RU2513997C1
Combined ophthalmic preparation presented in form of eye drops and containing polyhexamethylene guanidine and taurine
RU2509562C1
Ophthalmic preparation presented in form of eye drops and containing branched polyhexamethylene guanidines and poly(n-vinylpyrrolidone)
RU2505542C1
Hemihydrate of naltrexone base, method for its obtaining and method for microspheres manufacturing
RU2495663C1
Solid dosage form of taurine with improved pharmacological properties
RU2493841C1
Synergetic preparation for treating cardiovascular diseases, diabetes mellitus and hepatobiliary diseases
RU2495679C1
Disulphiram implant for treating alcohol or opiate addictive patients
RU2485939C1
Disulfiram and taurine-containing ophthalmological medication in form of eye drops
RU2476209C1
Implanted drug preparation of naltrexone for treating alcohol- or opioid-dependent patients
RU2475272C1
Implantable medication disulfiram-based for treatment of alcohol or opiate-dependent patient
RU2471478C1
Pharmaceutical composition for treating alcoholism, drug addiction and chemical abuse with improved naltrexone release profile
RU2471491C1
Use of n-vinylpyrrolidone copolymer as agent potentiating analgesic effect of morphine hydrochloride
RU2459838C1
Copolymer containing n-vinyl pyrrolidone, 2-methyl-5-vinyl pyridine and 4-vinyl pyridine links
WO2012082009A1
Branched oligomers on the basis of a guanidine derivative and disinfecting agent containing said oligomers (alternatives)
